PL3193934T3 - Kompozycje do poprawiania jakości życia uwarunkowanej stanem zdrowia u pacjentów z reumatoidalnym zapaleniem stawów - Google Patents

Kompozycje do poprawiania jakości życia uwarunkowanej stanem zdrowia u pacjentów z reumatoidalnym zapaleniem stawów

Info

Publication number
PL3193934T3
PL3193934T3 PL15779060T PL15779060T PL3193934T3 PL 3193934 T3 PL3193934 T3 PL 3193934T3 PL 15779060 T PL15779060 T PL 15779060T PL 15779060 T PL15779060 T PL 15779060T PL 3193934 T3 PL3193934 T3 PL 3193934T3
Authority
PL
Poland
Prior art keywords
compositions
improving
life
rheumatoid arthritis
health related
Prior art date
Application number
PL15779060T
Other languages
English (en)
Inventor
George Johny Joseph
Hubert VAN HOOGSTRATEN
Chieh-I CHEN
Chungpeng FAN
Neil Graham
Tanya Marie Momtahen
Mark Genovese
Original Assignee
Sanofi Biotechnology
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Biotechnology, Regeneron Pharmaceuticals, Inc. filed Critical Sanofi Biotechnology
Publication of PL3193934T3 publication Critical patent/PL3193934T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL15779060T 2014-09-16 2015-09-15 Kompozycje do poprawiania jakości życia uwarunkowanej stanem zdrowia u pacjentów z reumatoidalnym zapaleniem stawów PL3193934T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14306427 2014-09-16
EP15779060.1A EP3193934B1 (en) 2014-09-16 2015-09-15 Compositions for improving the health related quality of life of rheumatoid arthritis patients
PCT/US2015/050291 WO2016044343A1 (en) 2014-09-16 2015-09-15 Compositions for improving the health related quality of life of rheumatoid arthritis patients

Publications (1)

Publication Number Publication Date
PL3193934T3 true PL3193934T3 (pl) 2021-12-27

Family

ID=51619130

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15779060T PL3193934T3 (pl) 2014-09-16 2015-09-15 Kompozycje do poprawiania jakości życia uwarunkowanej stanem zdrowia u pacjentów z reumatoidalnym zapaleniem stawów

Country Status (9)

Country Link
US (1) US20170252434A1 (pl)
EP (2) EP3193934B1 (pl)
JP (4) JP7101479B2 (pl)
AU (2) AU2015317905A1 (pl)
CA (1) CA2961389A1 (pl)
ES (1) ES2894259T3 (pl)
PL (1) PL3193934T3 (pl)
PT (1) PT3193934T (pl)
WO (1) WO2016044343A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3417B1 (ar) 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
US10467343B2 (en) * 2017-08-03 2019-11-05 International Business Machines Corporation Detecting problematic language in inclusion and exclusion criteria
BR112021003206A2 (pt) 2018-08-29 2021-05-25 Regeneron Pharmaceuticals, Inc. métodos e composições para tratar indivíduos com artrite reumatoide
KR20210122810A (ko) 2019-01-31 2021-10-12 사노피 바이오테크놀로지 청소년 특발성 관절염을 치료하기 위한 항 il-6 수용체 항체
BR112021021077A2 (pt) * 2019-04-24 2021-12-14 E Zilberstein Moshe Métodos de diagnóstico e tratamento de artrite reumatoide
WO2020247461A1 (en) * 2019-06-04 2020-12-10 Sanofi Biotechnology Compositions and methods for treating pain in subj ects with rheumatoid arthritis
KR20230018443A (ko) * 2020-05-29 2023-02-07 사노피 바이오테크놀로지 류마티스 관절염이 있는 대상체에서 비염증성 통증을 치료하기 위한 조성물 및 방법
WO2023004072A1 (en) * 2021-07-21 2023-01-26 Slbst Pharma, Inc. Hydroxychloroquine formulations, dosage forms, and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6659982B2 (en) 2000-05-08 2003-12-09 Sterling Medivations, Inc. Micro infusion drug delivery device
US6629949B1 (en) 2000-05-08 2003-10-07 Sterling Medivations, Inc. Micro infusion drug delivery device
US20080131374A1 (en) * 2006-04-19 2008-06-05 Medich John R Uses and compositions for treatment of rheumatoid arthritis
TWI589299B (zh) * 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
US9943594B2 (en) * 2011-10-11 2018-04-17 Sanofi Biotechnology Methods for the treatment of rheumatoid arthritis
US20140120060A1 (en) * 2012-11-01 2014-05-01 Infinity Pharmaceuticals, Inc. Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors

Also Published As

Publication number Publication date
WO2016044343A1 (en) 2016-03-24
JP2020186260A (ja) 2020-11-19
CA2961389A1 (en) 2016-03-24
JP2024116246A (ja) 2024-08-27
US20170252434A1 (en) 2017-09-07
AU2021202702A1 (en) 2021-05-27
JP2022153653A (ja) 2022-10-12
EP3943109A1 (en) 2022-01-26
PT3193934T (pt) 2021-10-19
AU2015317905A1 (en) 2017-03-16
JP7101479B2 (ja) 2022-07-15
ES2894259T3 (es) 2022-02-14
JP2017538778A (ja) 2017-12-28
EP3193934A1 (en) 2017-07-26
EP3193934B1 (en) 2021-07-21

Similar Documents

Publication Publication Date Title
HK1245326A1 (zh) 用於生產scaav的組合物和方法
HK1232147A1 (zh) 用於治療纖維化的賽尼克韋羅
PT3193934T (pt) Composições para melhoria da qualidade de vida relacionada com a saúde de pacientes com artrite reumatoide
GB201402070D0 (en) Pharmaceutical compositions for the treatment of inflammatory disorders
SG11201606854YA (en) Health monitor
HK1244485A1 (zh) 用於治療神經母細胞瘤的組合物
IL241336A0 (en) Real-time simulation of fluoroscopic images
SI3273947T1 (sl) Sestavek za zdravje oči
GB201805634D0 (en) Health supplements
PL3122349T3 (pl) Kompozycje do leczenia samotrawienia
IL248267A0 (en) A process for preparing converted cycloserines
EP3042201A4 (en) Compositions and methods for the diagnosis of rheumatoid arthritis
PT3102130T (pt) Conjunto de parafuso ósseo
HK1257488A1 (zh) 骨形成
PL3174402T3 (pl) Proces produkcji proszku mlecznego
IL267059A (en) A preparation for the treatment of osteoarthritis
ZA201800752B (en) Improved prosthesis for osteosynthesis
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
ZA201605592B (en) Method of cleansing the colon
HUE046553T2 (hu) Eljárás pentosztatin szintézisére
GB201610646D0 (en) X-ray micro-beam production
GB201423406D0 (en) Health monitor
GB201418410D0 (en) use of compositions of matter
GB201407975D0 (en) Stabilization of the spine